BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Kashiv BioSciences Announces Positive Topline Results from Confirmatory Efficacy Study of ADL-018, Biosimilar Candidate to XOLAIR® (omalizumab)

  June 25, 2025

   · 

  4 min read
• Press Releases

  Parse Biosciences GigaLab to Support Mount Sinai Researchers in Generating One of the Largest Alzheimer’s and Parkinson’s Single Cell Datasets

  June 25, 2025

   · 

  3 min read
• Press Releases

  Ernexa Therapeutics Expands Advisory Board to Form Integrated Scientific and Medical Advisory Board as it Prepares for Clinical Development

  June 25, 2025

   · 

  5 min read
• Press Releases

  Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

  June 25, 2025

   · 

  5 min read
• Press Releases

  GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

  June 25, 2025

   · 

  4 min read
• Press Releases

  PreveCeutical Announces Date for Annual General and Special Meeting

  June 25, 2025

   · 

  2 min read
• Press Releases

  Novartis completes acquisition of Regulus Therapeutics

  June 25, 2025

   · 

  6 min read
• 

  Press Releases

  In sub-Saharan Africa, 1 in 6 cancer medications found to be defective

  June 25, 2025

   · 

  4 min read